Show Search Form
human indexable | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||
registered interest | |||||||||||||
answer date | |||||||||||||
date | |||||||||||||
date tabled | |||||||||||||
answering body |
|
||||||||||||
question status | Tabled | ||||||||||||
answering dept id | 17 | ||||||||||||
answering dept short name | Health | ||||||||||||
answering dept sort name | Health | ||||||||||||
ddp created |
|
||||||||||||
ddp modified |
|
||||||||||||
hansard heading | Radioisotopes: Imports | ||||||||||||
house id | 2 | ||||||||||||
identifier | HL1104 | ||||||||||||
legislature |
|
||||||||||||
parliament number | 57 | ||||||||||||
question first answered |
|
||||||||||||
question text | Her Majesty's Government (1) what assessment they have made of the potential impact of not reaching agreement with the EU by April 2019 on the supply of the radioisotope molybdenum-99 used to produce technetium-99m which is required for over 80 per cent of diagnostic medicine procedures in the UK; (2) what assessment they have made of the potential impact of delays or disruption to the supply of diagnostic medicine procedures that may result; and (3) what contingency plans they have put in place to mitigate such delays or disruption to that supply after Brexit. | ||||||||||||
session |
|
||||||||||||
session number | 1 | ||||||||||||
tabling member printed |
|
||||||||||||
title | House of Lords Tabled Parliamentary Question 2017/19 HL1104 | ||||||||||||
type |
|
||||||||||||
uin | HL1104 | ||||||||||||
version | 1 | ||||||||||||
written parliamentary question type | Ordinary | ||||||||||||
answer |
|
||||||||||||
creator |
|
||||||||||||
publisher |
|
||||||||||||
tabling member |
|